{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:09:12Z","timestamp":1794370152918,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01929-3","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T11:44:47Z","timestamp":1766231087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MOCRA: A multi-algorithm clinical decision support system for the early detection of ovarian cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Ahmadreza","family":"Safaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ghaderzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cirruse","family":"Salehnasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"3","key":"1929_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"S1","key":"1929_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","volume":"155","author":"JS Berek","year":"2021","unstructured":"Berek JS, Crum C, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(S1):61\u201385. https:\/\/doi.org\/10.1002\/ijgo.13878.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"1929_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","volume":"35","author":"C Stewart","year":"2019","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151\u20136. https:\/\/doi.org\/10.1016\/j.soncn.2019.02.001.","journal-title":"Semin Oncol Nurs"},{"key":"1929_CR4","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program: Ovarian Cancer Survival Statistics. 2022."},{"issue":"22","key":"1929_CR5","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","volume":"291","author":"BA Goff","year":"2004","unstructured":"Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705\u201312. https:\/\/doi.org\/10.1001\/jama.291.22.2705.","journal-title":"JAMA"},{"issue":"2","key":"1929_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ogc.2012.05.003","volume":"39","author":"U Menon","year":"2012","unstructured":"Menon U, Jacobs IJ. Ovarian cancer screening in the general population. Obstet Gynecol Clin North Am. 2012;39(2):353\u201366. https:\/\/doi.org\/10.1016\/j.ogc.2012.05.003.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"7","key":"1929_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-0528.2005.00572.x","volume":"112","author":"CR Bankhead","year":"2005","unstructured":"Bankhead CR, Kehoe ST, Austoker J. Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG. 2005;112(7):857\u201365. https:\/\/doi.org\/10.1111\/j.1471-0528.2005.00572.x.","journal-title":"BJOG"},{"issue":"2","key":"1929_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/cncr.22371","volume":"109","author":"BA Goff","year":"2007","unstructured":"Goff BA, Mandel LS, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index. Cancer. 2007;109(2):221\u20137. https:\/\/doi.org\/10.1002\/cncr.22371.","journal-title":"Cancer"},{"key":"1929_CR9","volume-title":"NG12: suspected cancer: recognition and referral","author":"National Institute for Health and Care Excellence (NICE)","year":"2015","unstructured":"National Institute for Health and Care Excellence (NICE). NG12: suspected cancer: recognition and referral. London: NICE; 2015."},{"key":"1929_CR10","volume-title":"Ovarian cancer referral pathway","author":"S Health","year":"2020","unstructured":"Health S. Executive (HSE). Ovarian cancer referral pathway. Ireland: HSE; 2020."},{"issue":"6","key":"1929_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/uog.5365","volume":"31","author":"D Timmerman","year":"2008","unstructured":"Timmerman D, Testa AC, Bourne T, Ameye L, Jurkovic D, Van Holsbeke C, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31(6):681\u201390. https:\/\/doi.org\/10.1002\/uog.5365.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"1929_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/1471-0528.12364","volume":"121","author":"N Nunes","year":"2014","unstructured":"Nunes N, Ambler G, Foo X, Naftalin J, Widschwendter M, Jurkovic D. Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis. BJOG. 2014;121(4):429\u201337. https:\/\/doi.org\/10.1111\/1471-0528.12364.","journal-title":"BJOG"},{"issue":"2","key":"1929_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.212555","volume":"305","author":"RF Andreotti","year":"2022","unstructured":"Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, et al. O-RADS US risk stratification and management system: updated 2022. Radiology. 2022;305(2):289\u2013303. https:\/\/doi.org\/10.1148\/radiol.212555.","journal-title":"Radiology"},{"key":"1929_CR14","doi-asserted-by":"publisher","first-page":"110266","DOI":"10.1016\/j.ejrad.2022.110266","volume":"150","author":"M Zhang","year":"2022","unstructured":"Zhang M, Li H, Li J, Li T. Diagnostic performance of O-RADS ultrasound system in adnexal masses: A systematic review and meta-analysis. Eur J Radiol. 2022;150:110266. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110266.","journal-title":"Eur J Radiol"},{"issue":"10","key":"1929_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","volume":"97","author":"I Jacobs","year":"1990","unstructured":"Jacobs I, Oram D, Fairbanks J, Turner J, Frost C, Grudzinskas JG. A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922\u20139. https:\/\/doi.org\/10.1111\/j.1471-0528.1990.tb02448.x.","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"1929_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","volume":"112","author":"RG Moore","year":"2009","unstructured":"Moore RG, McMeekin DS, Brown AK, DiSilvestro P, Miller MC, Allard WJ, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in women with a pelvic mass. Gynecol Oncol. 2009;112(1):40\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2008.08.031.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1929_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2217\/bmm.10.36","volume":"4","author":"BM Nolen","year":"2010","unstructured":"Nolen BM, Lokshin AE. Biomarkers for ovarian cancer: current status and future prospects. Biomark Med. 2010;4(3):373\u201384. https:\/\/doi.org\/10.2217\/bmm.10.36.","journal-title":"Biomark Med"},{"issue":"8","key":"1929_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1515\/cclm-2012-0817","volume":"51","author":"B Kristjansdottir","year":"2013","unstructured":"Kristjansdottir B, Levan K, Partheen K, Sundfeldt K. Diagnostic performance of in-house and commercial HE4 assays in ovarian cancer. Clin Chem Lab Med. 2013;51(8):1605\u201316. https:\/\/doi.org\/10.1515\/cclm-2012-0817.","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"1929_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3390\/diagnostics13050885","volume":"13","author":"A Czekierdowski","year":"2023","unstructured":"Czekierdowski A, Stachowicz N, Smolen A, Lozinski T, Guzik P, Kluz T. Performance of IOTA simple rules Risks, ADNEX Model, subjective assessment compared to CA125 and HE4 with ROMA algorithm. Diagnostics. 2023;13(5):885. https:\/\/doi.org\/10.3390\/diagnostics13050885.","journal-title":"Diagnostics"},{"issue":"3","key":"1929_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/cancers14030810","volume":"14","author":"SF Ngu","year":"2022","unstructured":"Ngu SF, Chai YK, Choi KM, Leung TW, Li J, Kwok GST, et al. Diagnostic performance of ROMA, RMI and expert ultrasound assessment in pelvic masses classified as inconclusive by IOTA simple rules. Cancers (Basel). 2022;14(3):810. https:\/\/doi.org\/10.3390\/cancers14030810.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1929_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/diagnostics11030414","volume":"11","author":"A Czekierdowski","year":"2021","unstructured":"Czekierdowski A, Stachowicz N, Smole\u0144 A, Kluz T, \u0141ozi\u0144ski T, Miturski A, et al. Sonographic assessment of complex adnexal tumors in pregnancy using IOTA simple rules and ADNEX. Diagnostics. 2021;11(3):414. https:\/\/doi.org\/10.3390\/diagnostics11030414.","journal-title":"Diagnostics"},{"issue":"1","key":"1929_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13048-020-00643-6","volume":"13","author":"A Hada","year":"2020","unstructured":"Hada A, Han LP, Chen Y, Hu QH, Yuan Y, Liu L. Comparison of RMI1\u20134, HE4, and ROMA in predicting malignant adnexal tumors. J Ovarian Res. 2020;13(1):46. https:\/\/doi.org\/10.1186\/s13048-020-00643-6.","journal-title":"J Ovarian Res"},{"issue":"5","key":"1929_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/bjc.2016.433","volume":"116","author":"EMJ Meys","year":"2017","unstructured":"Meys EMJ, Jeelof LS, Achten NM, Kaijser J, van den Bosch T, Vergote I, et al. Estimating risk of malignancy in adnexal masses: external validation of diagnostic models. Br J Cancer. 2017;116(5):573\u201381. https:\/\/doi.org\/10.1038\/bjc.2016.433.","journal-title":"Br J Cancer"},{"key":"1929_CR24","unstructured":"Rumbaugh J, Jacobson I, Booch G. The unified modeling Language reference manual. 2nd ed. Addison-Wesley; 2004."},{"issue":"1","key":"1929_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10447319509526110","volume":"7","author":"JR Lewis","year":"1995","unstructured":"Lewis JR. IBM computer usability satisfaction questionnaires: psychometric evaluation and instructions for use. Int J Hum Comput Interact. 1995;7(1):57\u201378. https:\/\/doi.org\/10.1080\/10447319509526110.","journal-title":"Int J Hum Comput Interact"},{"key":"1929_CR26","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. https:\/\/doi.org\/10.1136\/bmj.h5527.","journal-title":"BMJ"},{"issue":"10","key":"1929_CR27","doi-asserted-by":"publisher","first-page":"YE01","DOI":"10.7860\/JCDR\/2016\/18129.8744","volume":"10","author":"MA Bujang","year":"2016","unstructured":"Bujang MA, Adnan TH. Requirements for minimum sample size for sensitivity and specificity analysis. J Clin Diagn Res. 2016;10(10):YE01\u20136. https:\/\/doi.org\/10.7860\/JCDR\/2016\/18129.8744.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"1929_CR28","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/154193120204600409","volume":"46","author":"JR Lewis","year":"2002","unstructured":"Lewis JR. The psychometric evaluation of the Post-Study system usability questionnaire: the PSSUQ. Proc Hum Factors Ergon Soc Annu Meet. 2002;46(4):1259\u201360. https:\/\/doi.org\/10.1177\/154193120204600409.","journal-title":"Proc Hum Factors Ergon Soc Annu Meet"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01929-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01929-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01929-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:28:08Z","timestamp":1769779688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01929-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1929"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01929-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The protocol was reviewed and approved by the Ethics Committee of Yasuj University of Medical Sciences (Approval ID: IR.YUMS.REC.1402.178). Informed written consent was obtained from all participants before inclusion of their data in the CDSS development and evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual patient-identifiable data are presented.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}